kemn US officials laud enactment of K-P Police Act 2017

[Charlestesoiva]

Zbir The Panama leaks and Pakistani politics
MUMBAI/BENGALURU:India's IT lobby warned on Tuesday that a bill before the US Congress aimed at imposing tougher visa rules unfairly targets some of its members and will not solve a US labour shortage in technology and engineering.Industry lobby group Nasscom was responding to a bill introduced by Congresswoman Zoe Lofgren, a Democrat from California, that would double the minimum salary required for holders of H-1B visas to $130,000 and determine how many of the visas were allocated, based on fac samba adidas og tors such as overall wages.US hints at extending visa ban to PakistanIndia's $150 billion information technology sector, l ugg mini ed by Tata Consultancy Services (TCS.NS), Infosys Ltd (INFY.NS) and Wipro Ltd (WIPR.NS), uses the H-1B visas to fly engineers and developers to service clients in the US, their biggest market, but opponents say they are using the visas to replace US workers.Concerns abou adidas campus t President Donald Trump's immigration policies were heightened by his ban on refugees on Friday. "The Lo Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece inLancet by researchers from Imperia converse plateau l College London.Emerging evidence suggests that particular dr new balance ugs may benefit people from one ethnic group more than others, because of differences in their genetic makeup. However, most key trials looking at treatments for breast cancer have been carried out in predominantly white populations in Europe, North America and Australasia.Other populations might not respond to a drug in the same way as the white populations in these trials, argue the researchers.They suggest that clinical trials should record participants' ethnicity and analyze whether there are differences in how patie yeezy nts from particular ethnic groups respond to a particular therapy.The researchers highlight the example of a drug called trasztuzumab, which is commonly used to treat people with breast cancer that is HER-2 positive. M